Evommune, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | -7.5% | +195.8% | |
| – | -7.6% | +107.4% | |
| – | -44.0% | +171.1% | |
| – | -8.9% | +107.1% | |
| – | +37.7% | -91.2% | |
| – | +308.1% | -36.0% | |
| – | +32.4% | -42.1% | |
| – | +370.1% | -6.1% | |
| – | – | – | |
| – | – | – | |
| – | +0.0% | +4.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.